Evidence map›Paper›PMID 21593415›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Important roles of brain-specific carnitine palmitoyltransferase and ceramide metabolism in leptin hypothalamic control of feeding.

Su Gao, Guangjing Zhu, Xuefei Gao, Donghai Wu, Patricia Carrasco, Núria Casals, Fausto G Hegardt, Timothy H Moran, Gary D Lopaschuk

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Hypothalamic regulation of energy homeostasis: Quo vadis.Reviews in endocrine & metabolic disorders · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Shared Pathophysiological Mechanisms and Genetic Factors in Early Menarche and Polycystic Ovary Syndrome.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Contribution of specific ceramides to obesity-associated metabolic diseases.Cellular and molecular life sciences : CMLS · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Su GaoDepartment of Pediatrics, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada T6G 2S2.
Guangjing Zhu
Xuefei Gao
Donghai Wu
Patricia Carrasco
Núria Casals
Fausto G Hegardt
Timothy H Moran
Gary D Lopaschuk
Centro de Investigación Biomédica en Red · ESGuangzhou Institutes of Biomedicine and Health · CNUniversity of Alberta · CAJohns Hopkins Medicine · USJohns Hopkins University · US

Funding

JHU-UMD Diabetes Research CenterP30DK079637 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI AHIMA, REXFORD S. · 2013 to 2017
$9.7M
Gastrointestional Integration and FeedingR01DK019302 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MORAN, TIMOTHY H · 1986 to 2019
$7.1M
Gastrointestional Integration and FeedingR56DK019302 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MORAN, TIMOTHY H · 2010 to 2010
$720k
NIDDK NIH HHS DK19302NIDDK NIH HHS P30 DK079637NIDDK NIH HHS R01 DK019302NIDDK NIH HHS R56 DK019302
6 · The paper itself

Abstract

Brain-specific carnitine palmitoyltransferase-1 (CPT-1c) is implicated in CNS control of food intake. In this article, we explore the role of hypothalamic CPT-1c in leptin's anorexigenic actions. We first show that adenoviral overexpression of CPT-1c in hypothalamic arcuate nucleus of rats increases food intake and concomitantly up-regulates orexigenic neuropeptide Y (NPY) and Bsx (a transcription factor of NPY). Then, we demonstrate that this overexpression antagonizes the anorectic actions induced by central leptin or compound cerulenin (an inhibitor of fatty acid synthase). The overexpression of CPT-1c also blocks leptin-induced down-regulations of NPY and Bsx. Furthermore, the anorectic actions of central leptin or cerulenin are impaired in mice with brain CPT-1c deleted. Both anorectic effects require elevated levels of hypothalamic arcuate nucleus (Arc) malonyl-CoA, a fatty acid-metabolism intermediate that has emerged as a mediator in hypothalamic control of food intake. Thus, these data suggest that CPT-1c is implicated in malonyl-CoA action in leptin's hypothalamic anorectic signaling pathways. Moreover, ceramide metabolism appears to play a role in leptin's central control of feeding. Leptin treatment decreases Arc ceramide levels, with the decrease being important in leptin-induced anorectic actions and down-regulations of NPY and Bsx. Of interest, our data indicate that leptin impacts ceramide metabolism through malonyl-CoA and CPT-1c, and ceramide de novo biosynthesis acts downstream of both malonyl-CoA and CPT-1c in mediating their effects on feeding and expressions of NPY and Bsx. In summary, we provide insights into the important roles of malonyl-CoA, CPT-1c, and ceramide metabolism in leptin's hypothalamic signaling pathways.

Indexed as

AnimalsArcuate Nucleus of HypothalamusBlotting, WesternBody WeightBrainCarnitine O-PalmitoyltransferaseCeramidesCeruleninEatingHumansHypothalamusLeptinMaleMalonyl Coenzyme AMiceMice, KnockoutBSX protein, ratCarnitine O-PalmitoyltransferaseCeramidesCeruleninLeptinMalonyl Coenzyme ANerve Tissue ProteinsNeuropeptide YTranscription Factors

Identifiers

PMID21593415
PMCPMC3111271
OpenAlexW2016526819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.